Acticor Biotech SAS

EPA:ALACT.PA

0.362 (EUR) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

20232022202120202019201820172016201520142013201220112010
Revenue 000000.058.82813.8417.02819.76617.53615.01710.5686.703
Cost of Revenue 0.7280.0860.10.0990.07507.0629.29712.62311.5889.6887.6365.3634.166
Gross Profit -0.728-0.086-0.1-0.099-0.0750.051.7664.5434.4048.1787.8487.3815.2052.537
Gross Profit Ratio 0000010.20.3280.2590.4140.4480.4920.4930.379
Reseach & Development Expenses 14.4910.7619.1365.8513.6164.09200000000
General & Administrative Expenses 03.5692.3120.7620.8261.55300000000
Selling & Marketing Expenses 000.4760.0430.0640.05900000000
SG&A 4.883.5692.7880.8050.891.61200000000
Other Expenses -0.0650.772-0.0930.920.6580.1779.5514.6425.975.9635.1854.3062.7271.819
Operating Expenses 19.43515.10211.8317.5765.1645.8819.5514.6425.975.9635.1854.3062.7271.819
Operating Income -20.163-15.121-11.889-7.576-5.164-5.832-9.823-0.381-1.924-0.9722.4273.2232.5120.632
Operating Income Ratio 00000-116.64-1.113-0.028-0.113-0.0490.1380.2150.2380.094
Total Other Income Expenses Net -0.571-0.757-0.719-0.075-0.089-0.157-0.064-0.141-0.21500.297-0.00300.016
Income Before Tax -20.734-15.878-12.608-7.651-5.253-5.989-9.886-0.522-2.139-0.9722.7243.222.5120.648
Income Before Tax Ratio 00000-119.78-1.12-0.038-0.126-0.0490.1550.2140.2380.097
Income Tax Expense -2.0940.7570.5990.079-0.20.1570.48-0.048-0.783-0.0050.7660.9960.8430.21
Net Income -18.64-16.635-13.207-7.73-5.053-5.989-10.366-0.473-1.356-0.9671.9582.2241.6690.438
Net Income Ratio 00000-119.78-1.174-0.034-0.08-0.0490.1120.1480.1580.065
EPS -1.54-1.58-1.7-1.22-0.96-1.95-3.13-0.14-0.41-0.290.590.680.510.088
EPS Diluted -1.54-1.58-1.7-1.22-0.96-1.95-3.13-0.14-0.41-0.290.590.670.490.074
EBITDA -19.435-15.026-11.913-7.432-4.663-5.674-3.0280.13-1.4112.1573.0343.682.810.8
EBITDA Ratio 00000-113.48-0.3430.009-0.0830.1090.1730.2450.2660.119